3D Cell Culture 2017
Date: | 22-Feb-17 to 23-Feb-17 |
Location: | Copthorne Tara Hotel / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
Following the success of the sell-out Cell Based Assay series, SMi Group is delighted to launch its inaugural conference on 3D Cell Culture which takes place on the 22nd and 23rd of February 2017 in London.
The event is designed to address current and emerging applications of 3D cell culture, providing a platform for industry experts and clinical specialists within drug discovery, toxicology, stem cells, disease modelling and emerging technologies, to discuss the challenges and future directions of this technique.
With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine.
The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culture.
EXPERT SPEAKERS INCLUDE:
# Stefan Przyborski, Professor of Cell Technology, University of Durham
# Louisse Bisset, Senior Biologicals Quality Assessor, MHRA
# Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi-Aventis
# Rasdoslaw Polanski, Senior Research Scientist, AstraZeneca
# Robert Vries, Managing Director, Hubrecht Organoid Technology Foundations
# Olaf Galuba, Scientist, Novartis
# Christopher Schofield, Investigator, GlaxoSmithKline
and more!
For more information and to register, visit www.3D-cellculture.com/evvnt
The event is designed to address current and emerging applications of 3D cell culture, providing a platform for industry experts and clinical specialists within drug discovery, toxicology, stem cells, disease modelling and emerging technologies, to discuss the challenges and future directions of this technique.
With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine.
The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culture.
EXPERT SPEAKERS INCLUDE:
# Stefan Przyborski, Professor of Cell Technology, University of Durham
# Louisse Bisset, Senior Biologicals Quality Assessor, MHRA
# Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi-Aventis
# Rasdoslaw Polanski, Senior Research Scientist, AstraZeneca
# Robert Vries, Managing Director, Hubrecht Organoid Technology Foundations
# Olaf Galuba, Scientist, Novartis
# Christopher Schofield, Investigator, GlaxoSmithKline
and more!
For more information and to register, visit www.3D-cellculture.com/evvnt
Exhibitors
Durham University, MHRA, Sanofi, Sanofi Aventis, AstraZeneca, Novartics, GlaxoSmithKline, Lonza
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today